Aconitum Napellus Whole Magnesium Phosphate Dibasi
| 證據等級: L5 | 預測適應症: 0 個 |
目錄
- Aconitum Napellus Whole Magnesium Phosphate Dibasi
- Multi-Component Botanical Formula (Aconitum / Viscum / Toxicodendron): Insufficient Data for Repurposing Analysis
Multi-Component Botanical Formula (Aconitum / Viscum / Toxicodendron): Insufficient Data for Repurposing Analysis
One-Sentence Summary
This candidate is a six-component botanical/homeopathic combination containing Aconitum napellus, Magnesium phosphate, Pseudognaphalium obtusifolium, Rhododendron tomentosum, Toxicodendron pubescens, and Viscum album. The TxGNN pipeline returned no predicted indications for this compound, most likely because the multi-ingredient string could not be resolved to any DrugBank entry or knowledge-graph node. Without a DrugBank ID, MOA data, or regulatory approval in any surveyed market, no repurposing analysis can be performed at this stage.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | None on record |
| Predicted New Indication | None (TxGNN returned no candidates) |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 — model prediction only, no actual studies linked to this combined entity |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | Hold |
Why is This Prediction Reasonable?
No TxGNN prediction is available for this candidate; therefore, a mechanism-based rationale cannot be constructed from the evidence pack.
For context, the six named components suggest a homeopathic or phytotherapy combination:
- Aconitum napellus and Toxicodendron pubescens are classic homeopathic source materials used in highly diluted preparations (historically associated with pain and inflammatory conditions).
- Viscum album (European mistletoe) has a published oncology literature under the trade name Iscador / Helixor, typically used as an immunomodulatory adjunct.
- Rhododendron tomentosum and Pseudognaphalium obtusifolium are traditional herbal ingredients with limited modern pharmacological characterisation.
- Magnesium phosphate is a homeopathic mineral (Schüssler salt no. 7) associated with muscle cramps and neuralgia.
Because TxGNN’s knowledge graph operates on individual DrugBank-mapped molecules, it cannot score combinations of botanical extracts that lack a unified identifier. The pipeline failure is structural, not a negative prediction.
Clinical Trial Evidence
Currently no related clinical trials registered for this combined entity.
Literature Evidence
Currently no related literature available for this combined entity.
US Market Information
No US (FDA) authorisations found for this multi-component formula.
Safety Considerations
All safety fields returned no data for this candidate. Given that two of the six ingredients — Aconitum napellus and Toxicodendron pubescens — are derived from acutely toxic plants, the following general cautions apply even before formal package insert review:
- Aconitum napellus: source of aconitine; cardiotoxic and neurotoxic at non-homeopathic doses. Narrow therapeutic index.
- Toxicodendron pubescens: source of urushiol; potent contact allergen; systemic sensitisation risk.
- Viscum album: lectins and viscotoxins present; immunostimulant activity may interact with immunosuppressants.
Please refer to the respective component package inserts and homeopathic pharmacopoeia monographs before any clinical use.
Conclusion and Next Steps
Decision: Hold
Rationale: The multi-ingredient botanical string could not be resolved to a DrugBank node, so TxGNN produced zero predictions and no evidence linkage is possible. The candidate therefore cannot clear the minimum threshold for repurposing evaluation.
To proceed, the following is needed:
- Identifier resolution — Determine whether a single DrugBank ID or a compound-level FHIR identifier can represent this combination (e.g., if the product is a known marketed homeopathic brand such as a Boiron or Heel product, obtain its mapped ID).
- MOA data per ingredient — Query DrugBank individually for each of the six components (especially Viscum album lectin, aconitine, and urushiol) to support a component-level mechanism analysis.
- Regulatory status clarification — Confirm whether any US, EU, or Asia-Pacific homeopathic product licence exists for this exact formula, to populate the safety and indication fields.
- Safety review — Download and parse the full prescribing information or homeopathic product dossier before re-entering the TxGNN pipeline (blocking gap DG001).
- Re-run TxGNN per component — If the combination cannot be unified, run individual predictions for the pharmacologically active ingredients (Viscum album extract, Aconitum alkaloids) and aggregate results.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.